Arteris (AIP) Projected to Announce Quarterly Earnings on Thursday

Key Points

• Arteris is expected to report Q3 2026 results after market close on November 5. Analysts forecast a loss of $0.04 per share and revenue of $24.50 million, compared with the prior quarter’s $0.10-per-share loss and $24.13 million in revenue.
• The stock recently traded at $21.43, with a market capitalization of approximately $1.05 billion and a 52-week range of $12.06 to $50.26. Analysts hold a consensus “Moderate Buy” rating and an average price target of $37.29.
• Insiders have been selling shares: Arteris’s CEO and COO sold stock in October to cover tax obligations, while insiders sold 752,631 shares worth about $19.1 million over the past 90 days.

Arteris (NASDAQ:AIP - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Arteris to announce earnings of ($0.04) per share and revenue of $24.50 million for the quarter. Parties can check the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. The firm had revenue of $24.13 million during the quarter, compared to analysts' expectations of $23.48 million. On average, analysts expect Arteris to post ($0.68) EPS for the current fiscal year and ($0.37) EPS for the next fiscal year.

Arteris Trading Up 2.3%

NASDAQ:AIP opened at $21.43 on Thursday. The firm has a market capitalization of $1.05 billion, a P/E ratio of -24.63 and a beta of 1.90. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The company has a fifty day moving average of $22.14 and a 200 day moving average of $24.91. Arteris has a 52 week low of $12.06 and a 52 week high of $50.26.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AIP. Rosenblatt Securities restated a "buy" rating and issued a $38.00 price objective on shares of Arteris in a research report on Friday, August 7th. Roth Capital started coverage on shares of Arteris in a research note on Tuesday, August 4th. They set a "buy" rating and a $40.00 price objective for the company. Oppenheimer assumed coverage on shares of Arteris in a report on Thursday, July 16th. They set an "outperform" rating and a $40.00 target price for the company. TD Cowen cut their target price on Arteris from $40.00 to $25.00 and set a "buy" rating on the stock in a research note on Monday, October 19th. Finally, Jefferies Financial Group upgraded Arteris from a "hold" rating to a "buy" rating and boosted their price target for the company from $35.00 to $50.00 in a report on Friday, August 7th. Six equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $37.29.

Insider Transactions at Arteris

In other Arteris news, COO Laurent Moll sold 12,219 shares of the company's stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $24.29, for a total transaction of $296,799.51. Following the transaction, the chief operating officer owned 194,659 shares in the company, valued at approximately $4,728,267.11. This represents a 5.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO K Janac sold 11,452 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $24.27, for a total value of $277,940.04. Following the completion of the transaction, the chief executive officer directly owned 154,337 shares of the company's stock, valued at $3,745,758.99. This represents a 6.91% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 752,631 shares of company stock valued at $19,147,283. Insiders own 23.30% of the company's stock.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company's portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.